Colestyramine (International)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AC01

CAS registry number (Chemical Abstracts Service)

0011041-12-6

Therapeutic Category

Lipid lowering agent: Bile acid sequestrant

Chemical Name

A styrene-divinylbenzene copolymer containing quaternary ammonium groups.

Foreign Names

• Colestyraminum (Latin)
• Colestyramin (German)
• Colestyramine (French)
• Colestiramina (Spanish)

Generic Names

• Colestyramine (OS: BAN, DCF, JAN)
• Cholestyramine (IS)
• Cholestyramine Resin (IS)
• Cholestyramin-Harz (IS)
• Colestyraminum (IS)
• Divistyramine (IS)
• Holestiramin (IS)
• MK 325 (IS)
• Cholestyramine Resin (PH: USP 41)
• Colestyramine (PH: BP 2018, Ph. Eur. 9)
• Colestyraminum (PH: Ph. Eur. 9)
• Colestyramine Chloride (OS: BANM)

Brand Names

• Cholestamin
  Chi Sheng, Taiwan
• Cholestran
  Pharco, Egypt
• Cholestyramine Pharmascience
  Pharmascience, Hong Kong
• Cholestyramine-Odan
  Odan Laboratories, Canada
• Cholexamin
  Shinlin Sinseng, Taiwan
• Cinecolex
  Gramón Bagó, Uruguay
• Colestiramina Pharma Arte
  Pharma Arte, Paraguay
• Colestyramin HEXAL
  Hexal, Germany
• Colestyramin-ratiopharm
  ratiopharm, Germany
• Colestyr-CT
  AbZ-Pharma, Germany
• Efensol
  Lazlo, Spain
• Flotac [+ Diclofenac]
  Novartis, Chile
• Ipocol
  Lagap, Switzerland
• Kolestran
  Sandoz, Turkey
• Lipocol-Merz
  Merz Pharmaceuticals, Germany
• Olestyr
  Pharmascience, Canada
• PMS-Cholestyramine
  Pharmascience, Singapore; Pharmascience, Tunisia
• Prevalite
  Upsher-Smith, United States
• Prolertus [+ Diclofenac]
  Tecnofarma, Colombia
• Quantalan
  Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Portugal
• Questran
  Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Dr. Fisher Farma, Netherlands; GlaxoSmithKline, Egypt; IFET, Greece; Sanolabor, Slovenia
• Questran 44.4%
  Sanofi, Japan
• Questran 4g
  Bristol-Myers Squibb, Luxembourg
• Questran Light
  Bristol-M.S., Argentina; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Central Procurement & Supplies Unit, Malta
• Questran Lite
  Aspen, New Zealand; Aspen Pharmacare, Australia
• Questran Loc
  Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Sweden
• Questran-A
  BModesto, Netherlands; Bristol-Myers Squibb, Netherlands; Dr. Fisher Farma, Netherlands; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands
• Resincol
  Celsius, Uruguay
• Resincolestiramina
  Lab Rubio, Thailand; Laboratorios Rubio, Malta; Rubio, Spain; TTN, Thailand
• Semide
  Shun Sheng, Taiwan
• Sequest
  Novell Pharmaceutical, Indonesia
• Vasosan
  Felgenträger, Germany; IFET, Greece
• Choles
  Shyh Dar, Taiwan
• Questran
  Bristol-Myers Squibb, Italy

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer